RIG
55
-6
LB
60
4
AVY
54
-4
PLD
56
-5
EMC
56
-3
VTR
55
8
BBY
42
2
DLTR
40
-2
NWS
60
-4
F
54
-6
PYPL
56
-4
SWKS
51
-2
FCX
57
-2
PPL
59
5
NKE
39
-3
UAL
83
-2
NAVI
52
-3
V
72
-4
ADM
36
5
PNW
70
3
RIG
55
-6
LB
60
4
AVY
54
-4
PLD
56
-5
EMC
56
-3
VTR
55
8
BBY
42
2
DLTR
40
-2
NWS
60
-4
F
54
-6
PYPL
56
-4
SWKS
51
-2
FCX
57
-2
PPL
59
5
NKE
39
-3
UAL
83
-2
NAVI
52
-3
V
72
-4
ADM
36
5
PNW
70
3
Financhill
Back

Apollo Global Management Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
81

APO
Apollo Global Management

Last Price:
175.66
Seasonality Move:
9.21%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
130.47
Seasonality Move:
14.88%
Buy
81
Apollo Global Management (APO) is a Buy

Is Apollo Global Management a Buy, Sell or Hold?

  • The current Apollo Global Management [APO] share price is $175.64. The Score for APO is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
  • APO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APO Stock Price Chart

What is Apollo Global Management's stock price today?

  • The Apollo Global Management share price today is $175.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APO is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

APO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.06 Buy
Relative Strength Index (14 RSI): 73.95 Buy
Chaikin Money Flow: 2358519 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (146.01 - 168.33) Buy
Bollinger Bands (100): (109.32 - 149.02) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

APO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 167.75 Buy
20-day SMA: 160.27 Buy
50-day SMA: 144.78 Buy
200-day SMA: 121.06 Buy
8-day EMA: 168.73 Buy
20-day EMA: 161.37 Buy
50-day EMA: 147.69 Buy
200-day EMA: 122.81 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Apollo Global Management Earnings Growth & APO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and an increase next year of $1.40 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Apollo Global Management Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):